|
2020 Journal Article The future of faecal microbiota transplantation in gastrointestinal illnessReed, Hayley and Begun, Jakob (2020). The future of faecal microbiota transplantation in gastrointestinal illness. Microbiology Australia, 41 (2), 70-74. doi: 10.1071/ma20027 |
|
2020 Journal Article Aeromedical retrievals for gastrointestinal disorders in rural and remote Australia: the need for improved access to specialist adviceGardiner, Fergus W, Bishop, Lara, McMahon, Kathryn, Nwose, Ezekiel U, Connor, Susan, Begun, Jakob and Andrews, Jane M. (2020). Aeromedical retrievals for gastrointestinal disorders in rural and remote Australia: the need for improved access to specialist advice. Internal medicine journal, 50 (5), 619-623. doi: 10.1111/imj.14822 |
|
2020 Journal Article Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practiceHaifer, Craig, Kelly, Colleen R., Paramsothy, Sudarshan, Andresen, David, Papanicolas, Lito E., McKew, Genevieve L., Borody, Thomas J., Kamm, Michael, Costello, Samuel P., Andrews, Jane M., Begun, Jakob, Chan, Hiu Tat, Connor, Susan, Ghaly, Simon, Johnson, Paul D. R., Lemberg, Daniel A., Paramsothy, Ramesh, Redmond, Andrew, Sheorey, Harsha, van der Poorten, David and Leong, Rupert W. (2020). Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut, 69 (5) 320260, 801-810. doi: 10.1136/gutjnl-2019-320260 |
|
2020 Journal Article Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposureFlanagan, Emma, Gibson, Peter R., Wright, Emily K., Moore, Gregory T., Sparrow, Miles P., Connell, William, Kamm, Michael A., Begun, Jakob, Christensen, Britt, De Cruz, Peter, Shelton, Edward, Dowling, Damian, Andrews, Jane M., Brown, Steven J., Niewiadomski, Olga, Ward, Mark G., Rosella, Ourania, Rosella, Gennaro, Kiburg, Katerina V., Ross, Alyson L. and Bell, Sally J. (2020). Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Alimentary Pharmacology and Therapeutics, 52 (10), 1551-1562. doi: 10.1111/apt.16102 |
|
2020 Conference Publication Investigating the role of bioactives produced by gut bacteria to modulate immune response in inflammatory bowel diseaseGiri, R., Shamsunnahar, K., Salim, A., Capon, R., Morrison, M., Cuiv, P. O. and Begun, J. (2020). Investigating the role of bioactives produced by gut bacteria to modulate immune response in inflammatory bowel disease. 15th Congress of ECCO, Vienna, Austria, 12-15 February 2020. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjz203.035 |
|
2019 Journal Article MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiotaKoyama, Motoko, Mukhopadhyay, Pamela, Schuster, Iona S., Henden, Andrea S., Hülsdünker, Jan, Varelias, Antiopi, Vetizou, Marie, Kuns, Rachel D., Robb, Renee J., Zhang, Ping, Blazar, Bruce B., Thomas, Ranjeny, Begun, Jakob, Waddell, Nicola, Trinchieri, Giorgio, Zeiser, Robert, Clouston, Andrew D., Degli-Esposti, Mariapia A. and Hill, Geoffrey R. (2019). MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota. Immunity, 51 (5), 885-898. doi: 10.1016/j.immuni.2019.08.011 |
|
2019 Journal Article Malnutrition and quality of life among adult inflammatory bowel disease patientsPulley, Jessica, Todd, Alwyn, Flatley, Christopher and Begun, Jakob (2019). Malnutrition and quality of life among adult inflammatory bowel disease patients. JGH Open, 4 (3), 454-460. doi: 10.1002/jgh3.12278 |
|
2019 Journal Article Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysisAn, Yoon‐Kyo, Prince, David, Gardiner, Fergus, Neeman, Teresa, Linedale, Ecushla C., Andrews, Jane M., Connor, Susan and Begun, Jakob (2019). Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysis. Medical Journal of Australia, 211 (10) mja2.50384, 461-467. doi: 10.5694/mja2.50384 |
|
2019 Journal Article Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledgeRajagopalan, Arvind, Sathananthan, Dharshan, An, Yoon‐Kyo, Van De Ven, Lucinda, Martin, Serena, Fon, James, Costello, Samuel P, Begun, Jakob and Bryant, Robert V (2019). Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledge. JGH Open, 4 (2) jgh3.12268, 267-272. doi: 10.1002/jgh3.12268 |
|
2019 Journal Article Distinct tissue-specific roles for the disease-associated autophagy genes ATG16L2 and ATG16L1Khor, Bernard, Conway, Kara L., Omar, Abdifatah S., Biton, Moshe, Haber, Adam L., Rogel, Noga, Baxt, Leigh A., Begun, Jakob, Kuballa, Petric, Gagnon, John D., Lassen, Kara G., Regev, Aviv and Xavier, Ramnik J. (2019). Distinct tissue-specific roles for the disease-associated autophagy genes ATG16L2 and ATG16L1. The Journal of Immunology, 203 (7), ji1800419-1829. doi: 10.4049/jimmunol.1800419 |
|
2019 Journal Article MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activitySheng, Yong Hua, Wong, Kuan Yau, Seim, Inge, Wang, Ran, He, Yaowu, Wu, Andy, Patrick, Maya, Lourie, Rohan, Schreiber, Veronika, Giri, Rabina, Ng, Choa Ping, Popat, Amirali, Hooper, John, Kijanka, Gregor, Florin, Timothy H., Begun, Jakob, Radford, Kristen J., Hasnain, Sumaira and McGuckin, Michael A. (2019). MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity. Oncogene, 38 (48), 7294-7310. doi: 10.1038/s41388-019-0951-y |
|
2019 Journal Article Mindfulness based cognitive therapy experiences in youth with inflammatory bowel disease and depression: protocol for a mixed methods qualitative studyEwais, Tatjana, Begun, Jake, Kenny, Maura, Headey, Alan and Kisely, Steve (2019). Mindfulness based cognitive therapy experiences in youth with inflammatory bowel disease and depression: protocol for a mixed methods qualitative study. JMIR Research Protocols, 8 (7) e14432, e14432. doi: 10.2196/14432 |
|
2019 Conference Publication Immune responses to the microbiome tune MHC class II antigen presentation by the intestinal epithelium to control gut pathologyKoyama, Motoko, Mukhopadhyay, Pamela, Schuster, Iona S., Henden, Andrea S., Hülsdünker, Jan, Varelias, Antiopi, Vetizou, Marie, Kuns, Rachel D., Robb, Renee J., Zhang, Ping, Blazar, Bruce R., Thomas, Ranjeny, Begun, Jakob, Waddell, Nicola, Trinchieri, Giorgio, Zeiser, Robert, Clouston, Andrew D., Degli-Esposti, Mariapia A. and Hill, Geoffrey R. (2019). Immune responses to the microbiome tune MHC class II antigen presentation by the intestinal epithelium to control gut pathology. Immunology 2019™ Meeting, San Diego, CA United States, 9-13 May 2019. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.202.supp.69.38 |
|
2019 Journal Article Clinical decision support improves quality of care in patients with ulcerative colitisJackson, Belinda, Begun, Jake, Gray, Kathleen, Churilov, Leonid, Liew, Danny, Knowles, Simon and De Cruz, Peter (2019). Clinical decision support improves quality of care in patients with ulcerative colitis. Alimentary Pharmacology and Therapeutics, 49 (8), 1040-1051. doi: 10.1111/apt.15209 |
|
2019 Journal Article Protocol for a pilot randomised controlled trial of mindfulness-based cognitive therapy in youth with inflammatory bowel disease and depressionEwais, Tatjana, Begun, Jake, Kenny, Maura, Chuang, Kai-Hsiang, Barclay, Johanna, Hay, Karen and Kisely, Steve (2019). Protocol for a pilot randomised controlled trial of mindfulness-based cognitive therapy in youth with inflammatory bowel disease and depression. BMJ Open, 9 (4) e025568, e025568. doi: 10.1136/bmjopen-2018-025568 |
|
2019 Journal Article Interleukin-22: friend or foe?Hasnain, Sumaira Z. and Begun, Jakob (2019). Interleukin-22: friend or foe?. Immunology and Cell Biology, 97 (4), 355-357. doi: 10.1111/imcb.12249 |
|
2019 Conference Publication Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's diseaseLim, E., Thai, M., Hendy, P., Alchlaihawi, M., Leong, R., Connor, S., Ng, W., Gu, B., van Langenberg, D., Thin, L., Schulberg, J., Kamm, M., Gilmore, R., Taylor, K., Sallis, O., Andrews, J., Daker, C., Barclay, M., Wark, G., Ghaly, S., Begun, M., Krishnaprasad, K. and Begun, J. (2019). Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease. 14th Congress of ECCO, Copenhagen, Denmark, 6-9 March 2019. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjy222.647 |
|
2019 Conference Publication Effectiveness of fecal calprotectin testing to identify patients with organic gastrointestinal diseases: a systematic review and diagnostic meta-analysisAn, Y., Prince, D., Gardiner, F., Linedale, E., Andrews, J., Connor, S. and Begun, J. (2019). Effectiveness of fecal calprotectin testing to identify patients with organic gastrointestinal diseases: a systematic review and diagnostic meta-analysis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, South Australia, 8-10 September 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.14803 |
|
2019 Conference Publication On the role of inflammation in acute paracetamol injuryAlabbas, Saleh, Movva, Ramya, Begun, Jakob, Florin, Timothy and Oancea, Iulia (2019). On the role of inflammation in acute paracetamol injury. International Liver Congress, Vienna Austria, 10-14 April 2019. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0618-8278(19)30823-0 |
|
2019 Conference Publication Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort studyHaifer, C., Srinivasan, A., Menon, S., An, Y., Picardo, S., Van Langenberg, D., Begun, J., Ghaly, S. and Thin, L. (2019). Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA, Australia, 8–10 September 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.14801 |
